▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Hospital

Oct 30, 2018 by Keith Speights

Why Community Health Systems, Inc. Stock Is Tanking Today

The hospital operator disappointed Wall Street big-time with its Q3 results.

Marijuana buds on top of money

Oct 29, 2018 by Keith Speights

Hexo Corp.'s Elixir Fuels Strong Fourth-Quarter Sales Growth

The Canadian marijuana grower's revenue skyrockets in its fiscal fourth quarter -- but so does its spending.

Marijuana leaf on top of $100 bill

Oct 29, 2018 by Keith Speights

3 Marijuana Stocks to Buy After the Market Meltdown

The stock market just gave investors a gift -- three marijuana stocks with great growth prospects that can be bought at bargain prices.

White pills on top of $100 bill

Oct 28, 2018 by Keith Speights

This Big Pharma Bet Isn't Paying Off Yet -- and It's Costing You

Who's paying the price tag for big pharma's big bet, which hasn't delivered impressive returns? Look in the mirror.

Marijuana leaf with money in background

Oct 28, 2018 by Keith Speights

Better Marijuana Stock: Aurora Cannabis vs. MariMed

Which stock wins in a one-on-one battle between a big Canadian cannabis producer and a top U.S. cannabis company?

Marijuana leaf in drink

Oct 28, 2018 by Keith Speights

Better Buy: Canopy Growth Corporation vs. Constellation Brands

It's Corona battling cannabis in a matchup between these two stocks.

Biotech concept

Oct 28, 2018 by Keith Speights

Better Buy: Vertex Pharmaceuticals Incorporated vs. Incyte Corporation

Which stock wins in a matchup between these two biotechs?

Marijuana leaves surrounding red Canadian maple leaf

Nov 4, 2018 by Keith Speights

Better Marijuana Stock: Tilray vs. CannTrust Holdings

Which stock wins in a matchup between these two Canadian marijuana producers?

ISRG da Vinci system photo

Oct 28, 2018 by Keith Speights

Is Intuitive Surgical, Inc. a Buy?

Three reasons why the robotic surgical systems stock still looks like a long-term winner.

Hands holding $100 bills and a cannabis leaf

Oct 28, 2018 by Keith Speights

Meet the New Marijuana Stock That's Trouncing Aurora Cannabis and Canopy Growth

And it happens to be No. 1 in an important component of the world's biggest marijuana market, too.

Weighing the options

Oct 28, 2018 by Keith Speights

Better Buy: Cara Therapeutics, Inc. vs. Scotts Miracle-Gro Company

Which stock wins in a matchup between a high-flying clinical-stage biotech and a leading supplier to the marijuana industry?

Scientist at microscope

Oct 27, 2018 by Keith Speights

Better Buy: Intercept Pharmaceuticals Inc. vs. Madrigal Pharmaceuticals

Which stock wins in a matchup between these biotechs hoping for success with promising NASH drugs?

Management watching stock tank

Oct 26, 2018 by Keith Speights

Why Cerner Stock Is Sinking Today

A blah earnings update combined with the broader market sell-off results in a double whammy for the healthcare technology provider.

Doctor with stethescope touching computer interface

Oct 26, 2018 by Keith Speights

Services Rather Than Software Drive Cerner's 3rd-Quarter Growth

The healthcare-technology provider delivers modest growth, thanks to increasing professional and managed-services revenue.

Flask and lab background

Oct 26, 2018 by Keith Speights

Gilead Sciences' 3rd Quarter: Good News Gets Better, Bad News Gets Worse

The big biotech reported similar results from the third quarter -- rising HIV sales and falling HCV sales.

Dentist with patient pointing to smile

Oct 25, 2018 by Keith Speights

Why Align Technology, Inc. Stock Is Plunging Today

The high-flying stock sold off after the orthodontic specialist's Q3 report disappointed investors.

Dentist with patient

Oct 25, 2018 by Keith Speights

Lower Invisalign Prices Slow Align Technology Inc.'s Third-Quarter Growth

The orthodontic-device maker reports strong but slowing sales and earnings growth in the third quarter.

Energy drinks top view

Oct 24, 2018 by Keith Speights

Why New Age Beverages Stock Fizzled Again Today

Another day of volatility for marijuana stocks hit this beverage company harder than many.

Businessman pointing to healthcare icons

Oct 24, 2018 by Keith Speights

3 Healthcare Stocks I'd Buy Right Now

There's a lot to like about these healthcare stocks.

DNA image over hand

Oct 24, 2018 by Keith Speights

lllumina Inc. Posts Highest Sequencing System Sales in 3 Years

The genomic-sequencing leader reported moderating consumables growth but a nice jump in instrument sales during the third quarter.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services